Alimera Price To Operating Cash Flows Ratio from 2010 to 2024

ALIM Stock  USD 2.89  0.12  3.99%   
Alimera Sciences Price To Operating Cash Flows Ratio yearly trend continues to be very stable with very little volatility. Price To Operating Cash Flows Ratio is likely to drop to -8.13. During the period from 2010 to 2024, Alimera Sciences Price To Operating Cash Flows Ratio quarterly data regression pattern had range of 9.6374 and standard deviation of  3.42. View All Fundamentals
 
Price To Operating Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
(7.74)
Current Value
(8.13)
Quarterly Volatility
3.41516871
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Alimera Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alimera Sciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.2 M, Interest Expense of 10.7 M or Selling General Administrative of 11.1 M, as well as many indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.0 or PTB Ratio of 2.51. Alimera financial statements analysis is a perfect complement when working with Alimera Sciences Valuation or Volatility modules.
  
Check out the analysis of Alimera Sciences Correlation against competitors.
To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.

Latest Alimera Sciences' Price To Operating Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Operating Cash Flows Ratio of Alimera Sciences over the last few years. It is Alimera Sciences' Price To Operating Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alimera Sciences' overall financial position and show how it may be relating to other accounts over time.
Price To Operating Cash Flows Ratio10 Years Trend
Slightly volatile
   Price To Operating Cash Flows Ratio   
       Timeline  

Alimera Price To Operating Cash Flows Ratio Regression Statistics

Arithmetic Mean(5.40)
Coefficient Of Variation(63.28)
Mean Deviation3.10
Median(4.35)
Standard Deviation3.42
Sample Variance11.66
Range9.6374
R-Value(0.59)
Mean Square Error8.14
R-Squared0.35
Significance0.02
Slope(0.45)
Total Sum of Squares163.29

Alimera Price To Operating Cash Flows Ratio History

2024 -8.13
2023 -7.74
2022 -1.9
2021 -10.49
2020 -9.85
2019 -8.71
2018 -4.35

About Alimera Sciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Alimera Sciences income statement, its balance sheet, and the statement of cash flows. Alimera Sciences investors use historical funamental indicators, such as Alimera Sciences's Price To Operating Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Although Alimera Sciences investors may use each financial statement separately, they are all related. The changes in Alimera Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alimera Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Alimera Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Alimera Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Operating Cash Flows Ratio(7.74)(8.13)

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Alimera Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in Alimera Stock

When determining whether Alimera Sciences is a strong investment it is important to analyze Alimera Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alimera Sciences' future performance. For an informed investment choice regarding Alimera Stock, refer to the following important reports:
Check out the analysis of Alimera Sciences Correlation against competitors.
To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.25)
Revenue Per Share
2.413
Quarterly Revenue Growth
0.699
Return On Assets
(0.01)
Return On Equity
(1.97)
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.